Generate Biomedicines, Inc. (NASDAQ:GENB) IPO

Generate Biomedicines, Inc.

IPO

Priced at US$16.00 a share on Feb 26, 2026.

Price
US$16.00 a share
Shares offered
25,000,000 shares of common stock
Offering size
US$400 million
Underwriters' option
Up to 3,750,000 more shares
Listing
GENB on the Nasdaq Global Select Market
Underwriters
Goldman Sachs & Co. LLC, Morgan Stanley, Piper Sandler, Guggenheim Securities, Cantor · In the order on the cover
Shares delivered
On or about Mar 2, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceDec 23, 2025
Filed publiclyFeb 4, 2026
Amended twiceNewest Feb 23, 2026
Shares registered with an exchangeFeb 24, 2026
Declared effective by the SECFeb 26, 2026
Final prospectus, with the priceFeb 27, 2026

From the cover of the final prospectus (424B4) filed Feb 27, 2026